Waregem, 3 November 2008 – In accordance with the stipulations of article 29 of the Act of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus informs that it had 964,358 voting rights (treasury shares) on 24 October 2008, after closing of Euronext Amsterdam/Brussels.
Based on this notification and earlier received notifications and the denominator of 31,195,121 (total number of voting rights), the structure of the shareholding of Arseus is as follows:
Fortis Investment Management SA
8.84%
Omega Pharma NV*
24.04%
Couckinvest NV / Coucke*
12.37%
Arseus NV (treasury shares)
3.09%
Public
51.66%
* related parties
The original notification forms are also available on the corporate website (www.arseus.com).
This is a translation of the Dutch press release; the Dutch press release prevails.
For further information:
Constantijn van Rietschoten, Investor Relations Manager
+31 6 536 91 585 (mobile)